Press Releases by Category Health & Medicine
Cervical Cancer Drug Market & Pipeline Insight
`Cervical cancer is the third and fourth most common cause of cancer incidence and mortality among women across the world. Though there has been a decline in cervical cancer mortality rates in the previous few years, owing to early detection and intervention, challenges like over-diagnosis and over-treatment of the disease continue to remain. As per the World Health Organization (WHO), more than half a million new cases are diagnosed annually…
Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014
The conventional methods developed to prevent and eradicate the prevalence of cancer have achieved limited success in cancer treatment. These methods are confined to low specificity, safety and large number of side effects, which prompted the researchers to look for a better solution. It has been discovered that peptides can be used for effective and viable treatment of cancer without having disadvantages of conventional methods. The quintessential for using peptide…
US Orphan Drug Pipeline Insight 2014
Rare diseases are also known as Orphan diseases. These diseases are generally categorized as chronic, degenerative, and life-threatening in nature. The rare diseases normally include certain cancers, metabolic conditions, diseases of the nervous system and musculoskeletal disorders, which are extremely life-threatening. As per the official definition, rare diseases are classified as those that affect fewer than 200,000 in the US and less than 5 in 10,000 in the EU.
The…
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the…
Medical Aesthetic Devices Market to Reach $17,992 Million, Globally, by 2023
According to a new report published by Allied Market Research, titled, Medical Aesthetic Devices Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global medical aesthetic devices market was valued at $9,235 million in 2016, and is expected to reach at $17,992 million by 2023, growing at a CAGR of 10.0% from 2017 to 2023. The dental implants segment accounted for more than one-third…
Europe Orphan Drug Market & Clinical Trial Insight 2015
The concept of rare diseases and the idea that a special attention needs to be given to this sector has been taking shape in Europe since the 1990s. ever since then the political aspects and initiatives related to orphan medicinal products have been emerging at both the EU level and at the level of member states individually. Many member states in the EU have led the way during the 1990s…
Global Travelers Vaccines Market Research Reports 2017 Serve Growth Markets Prof …
Travelers Vaccines Market Research
Report Monitor Present's Global Travelers Vaccines Market 2017 Industry Trend Enhances The Decision Making Capabilities And Helps To Create An Effective Counter Strategies To Gain Competitive Advantage.
Description
The Global Travelers Vaccines Report Offers A Comprehensive Evaluation Of The Global Travelers Vaccines Industry. This Report Evaluates The Global Market For "Global Travelers Vaccines".
The Global Travelers Vaccines Report Provides Complete Analysis Of The Global Travelers Vaccines By Analysing…
Global Orphan Drug Pipeline & Regulatory Insight 2015
Rare diseases are also known as Orphan diseases. These diseases are generally categorized as chronic, degenerative, life threatening in nature and normally include certain cancers, metabolic conditions, diseases of the nervous system and musculoskeletal disorders. As per the official definition, rare diseases are classified as those that affect fewer than 200,000 in the United States and less than 5 in 10,000 in the EU. These two regions form a dominant…
Global Prostate Cancer Vaccine Clinical Pipeline Insight 2015
Prostate cancer has emerged as a disease with one of the highest incidences and mortality rates in males across the world. This situation has created a large unmet medical demand for better therapeutics by patients suffering from prostate cancer due to modest response generated by presently available therapeutics. Hormone based therapeutics and chemotherapeutics helped in improving the patient’s condition but they have side effects and modest pharmacological benefits reflecting necessity…
Global Medical Video System Center Sales Market 2017 Size By Application, Type, …
"The Latest Research Report Global Medical Video System Center Sales Market Report 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Medical Video System Center Sales Market
In this report, the global Medical Video System Center market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR…
Global Medical Flow Twin Valve Sales Market 2017 Size By Players, And Segment Ma …
"The Latest Research Report Global Medical Flow Twin Valve Sales Market Report 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Medical Flow Twin Valve Sales Market
In this report, the global Medical Flow Twin Valve market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR…
Membrane Microfiltration Market to Reach $12,858 Million, Globally, by 2022
Membrane Microfiltration Market Report, published by Allied Market Research, forecasts that the global market was valued at $6,769 million in 2015, and is expected to reach $12,858 million by 2022, supported by a CAGR of 9.6% during the forecast period 2014 - 2022.
Access Full Summary @ https://www.alliedmarketresearch.com/membrane-microfiltration-market
The cross-flow segment accounted for more than half of the market share of the global market in 2015, owing to the varied use of…
Small Molecule Cancer Drug Clinical Pipeline Insight
Oncologists are continuously looking for better therapeutic options to effectively cure and prevent different types of malignancies. Conventionally, surgery and radiation were widely used for cancer treatment but they have modest benefits. Presently, global market consists of several options for cancer treatment which belongs to various classes of molecules. Their utilization in therapeutic regime depends on the patient’s medical condition, pharmacological and financial benefits offered by them during treatment. Out…
Subcutaneous Drug Delivery Market & Pipeline Insight
Subcutaneous sites along with intramuscular and intravenous sites are part of parenteral route of drug entry. Maximum pharmacological benefits of a drug could be achieved by deciding effective route of administration depending upon pharmacodynamic properties of the drug to be used. Subcutaneous route is commonly used for the administration of therapeutics into the body for better drug delivery of lipophilic, proteinecious, small molecule drugs. It is characterized by less vasculature,…
Global Peptide Therapeutics Pipeline Insight 2015
Peptides are small molecules of varying molecular masses that consist of amino acids joined with the help of peptide bonds (CONH2). One end of the molecule consists of carboxyl (COOH2) group while the other end has amino (NH2) group giving rise to polarity. Biologically, they are very important and found to play an important role in various anabolic and catabolic processes. They are essential component of cell signaling pathways, immune…
Metal Replacement Market : Recent Industry Trends and Projected Industry Growth, …
Global Metal Replacement Market: Overview
Development and manufacturing of new products require more resources and are more complex than ever. As a result, the limelight is slowly shifting towards metal replacement. It is being widely acknowledged for reducing weight, production, and cost times. Metal replacement materials are used across industries such as aerospace and defense, automotive, healthcare, and construction. The materials used are engineering plastics and composites such as carbon…
Single Sign-on Market: Industry Research and Forecast Analysis 2017
Global Single Sign-on Market: Overview
Single sign-on (SSO) is an authenticated session, which permits a user to access applications based on one set of login credentials such as user-id and password. Based on the permissions granted to the user, single sign-on allows and restricts further prompts. SSO is particularly helpful for tracking user activities, both on the real-time as well as creating log-database for future analytics. With technological advancements and widespread…
Managed Services Market: Evolving Technology, Trends and industry Analysis 2025
Global Managed Services Market: Overview
Managed Services are the exercise of outsourcing on a daily and active basis of management functions and responsibilities and a planned method for the purpose of cutting down expenses and improving operations. It is a substitute for on-demand or break/fix model in which the service provider executes on-demand services and charges the customer only for the task achieved. Under this type of subscription model, the customer…
Deep Research on Insomnia Market studies Research Report 2025
Global Insomnia Market: Overview
Disorders or diseases without absolute treatment have always been lucrative for the players, as it leaves ample of opportunity for innovative treatment programs and introduction of new drugs. Insomnia forms a similar condition, which is quite apparent across the world but no defined compound has yet been discovered that can cure it completely. Recently in March 2015, Merck introduced its new insomnia drug called Belsomra, which is…
Humanized Mouse Model Market: Industry Research and Forecast Analysis 2017
Global Humanized Mouse Model Market: Snapshot
The pharmaceutical industry has been experiencing a consistent surge in the past decade, owing to rising prevalence of a number diseases, and biotechnology promises to revolutionize the field going forward. This surge is quite evident on the global humanized mouse model market too, which is based on humanizing mice with a short strand of human DNA, tissue, tumor, or microbiome. The mice that are humanized…
Global Monoclonal Antibodies Pipeline Insight 2015
Ever since the Nobel Prize was bestowed on the person who invented the technology which enabled the preparation of monoclonal antibodies in 1984, their use has considerably expanded far beyond the scientific realm. Paul Ehrlich framed a hypothesis that a “magic bullet” could be developed with an objective of targeting selective diseases. With the introduction and development of hybridoma technology by Kohler and Milstein, this hypothesis has become a reality.…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size – Industry Sh …
Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Overview
In recent times, the global cardiac monitoring and cardiac rhythm management devices market has exhibited a phenomenal growth rate. Rapid technological advancements and the advent of innovative products such as MRI pacemakers, durable batteries, and biocompatible materials are providing a significant boost to the market. Cardiac monitoring and cardiac rhythm management devices are primarily used in hospitals, home, and ambulatory…
Global Multiple Myeloma Market to grow at a CAGR of 4.8% and reach $ 9.1 billion …
According to the report “Global Multiple Myeloma Market" published by Market Data Forecast, the global market is projected to reach USD 9.1 billion by 2021 from USD 7.2 billion in 2016, at a CAGR of 4.8%.
Multiple Myeloma is a rare form of cancer caused due to malignant plasma cells. When plasma cells become cancerous, they produce a tumour called plasmacytoma. If someone has more than one plasmacytoma, they have multiple…
Bioprocess Technology Market 2017 Industry Demand, Segment, Statistics Report 20 …
Global Bioprocess Technology Market: Overview
Bioprocess technology forms the backbone of the biotechnology industry. In a bioprocess living cells such as bacteria, enzymes, and chloroplast or their components are used to procure desired products. The process is leveraged to develop industrial products, processes and techniques to fulfill the needs of society. The different stages in bioprocess includes formulating raw materials, substrates and media, the conversion state, biocatalysts, downstream processing, volume…
Global Peptide Therapeutics Market & Clinical Pipeline Insight 2016
Investigators are looking for different molecular entities that could be used for the development of viable therapeutics with commercial potential. Peptide therapeutics are one such category that has gained significant attention in past years. Several products have been launched in global market for different indications. Significant investments have been made by pharmaceutical companies in research and development (R&D) segment in order to come forth with innovative products. They also serve…
Agenus-Cancer Drugs Clinical Pipeline Insight
“Agenus-Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Agenus. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “8” cancer drugs in clinical pipeline and majority of them are in preclinical phase. There is 1 cancer drug by Agenus which are commercially available in the market.
The…
Ajinomoto - Cancer Drugs Clinical Pipeline Insight
“Ajinomoto - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Ajinomoto. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “2” cancer drugs in clinical pipeline. There are 3 cancer drugs by Ajinomoto which are commercially available in the market.
The report includes all the relevant information…
Alnylam Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight
“Alnylam Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Alnylam. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “9” cancer drugs in clinical pipeline.
The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps…
Alphamab - Cancer Drugs Clinical Pipeline Insight
“Alphamab - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Alphamab. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “13” cancer drugs in clinical pipeline and majority of them are in preclincal phase.
The report includes all the relevant information with respect to development of cancer…
Antigenics - Cancer Drugs Clinical Pipeline Insight
“Antigenics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Antigenics. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “8” cancer drugs in clinical pipeline and majority of them are in preclincal phase. There are 2 cancer drugs by Antigenics which are commercially available in the…
Arbutus Biopharma-Cancer Drugs Clinical Pipeline Insight
“Arbutus Biopharma-Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Arbutus. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “6” cancer drugs in clinical pipeline and majority of them are in prclinical phase. There is 1 cancer drug by Arbutus Biopharma which is commercially available in the…
ARAID Pharmaceuticals-Cancer Drugs Clinical Pipeline Insight
“ARAID Pharmaceuticals-Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by ARAID Pharmaceuticals. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “6” cancer drugs in clinical pipeline and majority of them are in preclincal phase. There is 1 cancer drug by ARIAD Pharmaceuticals which is commercially available in…
Arqule-Cancer Drugs Clinical Pipeline Insight
“Arqule-Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Arqule. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “9” cancer drugs in clinical pipeline.
The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying…
Aurigene Discovery Technologies-Cancer Drugs Clinical Pipeline Insight
“Aurigene Discovery Technologies-Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Aurigene Discovery Technologies. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “10” cancer drugs in clinical pipeline and majority of them are in preclinical phase.
The report includes all the relevant information with respect to development of…
BTG - Cancer Drugs Clinical Pipeline Insight
“BTG - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by BTG. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “8” cancer drugs in clinical pipeline. There are 4 cancer drugs by BTG which are commercially available in the market.
The report includes all the relevant information…
Cardiff University - Cancer Drugs Clinical Pipeline Insight
“Cardiff University - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Cardiff University. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “12” cancer drugs in clinical pipeline and majority of them are in phase-III.
The report includes all the relevant information with respect to development of cancer…
Celtic Pharma - Cancer Drugs Clinical Pipeline Insight
“Celtic Pharma - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Celtic Pharma. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there is “1” cancer drug in clinical pipeline.
The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report…
Cephalon-Cancer Drugs Clinical Pipeline Insight
“Cephalon-Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Cephaloan. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “13” cancer drugs in clinical pipeline and majority of them are in preclinical phase. There are 3 cancer drugs by Cephalon which are commercially available in the market.
The…
Curis - Cancer Drugs Clinical Pipeline Insight
“Curis - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Curis. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “7” cancer drugs in clinical pipeline. There is 1 cancer drug by Curis which are commercially available in the market.
The report includes all the relevant information…
Debiopharma - Cancer Drugs Clinical Pipeline Insight
“Debiopharma - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Debiopharma. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “5” cancer drugs in clinical pipeline. There are 2 cancer drugs by Debiopharma which are commercially available in the market.
The report includes all the relevant information…
Dendreon Corporation - Cancer Drugs Clinical Pipeline Insight
“Dendreon Corporation - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Dendreon Corporation. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there is “1” cancer drug in clinical pipeline. There is 1 cancer drug by Dendreon Corporation which is commercially available in the market.
The report includes all…
Eisai Co. Ltd Cancer Drugs Clinical Pipeline Insight
“Eisai Co. Ltd Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Eisai Co. Ltd. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “31” cancer drugs in clinical pipeline and majority of them are in preclinical phase. There are 15 cancer drugs by Eisai Co. Ltd. which…
Endocyte - Cancer Drugs Clinical Pipeline Insight
“Endocyte - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Endocyte. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “8” cancer drugs in clinical pipeline.
The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader…
Enzon Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight
“Enzon Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Enzon Pharmaceuticals. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “4” cancer drugs in clinical pipeline. There are 2 cancer drugs by Enzon Pharmaceuticals which are commercially available in the market.
The report includes all…
Evotec AG - Cancer Drugs Clinical Pipeline Insight
“Evotec AG - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Evotec AG. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “11” cancer drugs in clinical pipeline and majority of them are in research phase.
The report includes all the relevant information with respect to development of…
Hospira - Cancer Drugs Clinical Pipeline Insight
“Hospira - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Hospira. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “3” cancer drugs in clinical pipeline and majority of them are in preregistration phase. There are 8 cancer drugs by Hospira which are commercially available in the…
Idera Pharmaceutical - Cancer Drugs Clinical Pipeline Insight
“Idera Pharmaceutical - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Idera Pharmaceutical. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “6” cancer drugs in clinical pipeline and majority of them are in preclincal phase.
The report includes all the relevant information with respect to development of…
Immunomedics - Cancer Drugs Clinical Pipeline Insight
“Immunomedics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Immunomedics. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “13” cancer drugs in clinical pipeline and majority of them are in preclinical phase.
The report includes all the relevant information with respect to development of cancer drugs…
Introgen Therapeutics - Cancer Drugs Clinical Pipeline Insight
“Introgen Therapeutics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Introgen Therapeutics. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there is “1” cancer drug in clinical pipeline.
The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps…
Jiangsu Hengrui Medicine Co. - Cancer Drugs Clinical Pipeline Insight
“Jiangsu Hengrui Medicine Co. - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Jiangsu Hengrui Medicine Co. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “13” cancer drugs in clinical pipeline and majority of them are in phase-I. There is 1 cancer drug by Jiangsu Hengrui…
Go To Page 1045 1044 1043 1042 1041 1040 1039 1038 1037 1036
